Injectable thermo-sensitive hydrogel loaded hollow copper sulfide nanoparticles for ROS burst in TME and effective tumor treatment

Shipeng Ning,Jianlan Mo,Rong Huang,Benkun Liu,Bicheng Fu,Shuaijie Ding,Huawei Yang,Ying Cui,Lei Yao
DOI: https://doi.org/10.3389/fbioe.2023.1191014
IF: 5.7
2023-05-03
Frontiers in Bioengineering and Biotechnology
Abstract:Introduction: Lung cancer the most prevalent cause of cancer-related deaths, and current therapies lack sufficient specificity and efficacy. This study developed an injectable thermosensitive hydrogel harboring hollow copper sulfide nanoparticles and β-lapachone (Lap) (CLH) for lung tumor treatment. Methods: The hydrogel-encapsulated CLH system can remotely control the release of copper ions (Cu 2+ ) and drugs using photothermal effects for non-invasive controlled-release drug delivery in tumor therapy. The released Cu 2+ consumes the overexpressed GSH in TME and the generated Cu + further exploits the TME characteristics to initiate nanocatalytic reactions for generating highly toxic hydroxyl radicals. In addition, in cancer cells overexpressing Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase 1 (NQO1), Lap can catalyze the generation of hydrogen peroxide (H 2 O 2 ) through futile redox cycles. H 2 O 2 is further converted into highly toxic hydroxyl radicals via the Fenton-like reaction, leading to a burst of reactive oxygen species in TME, which further enhances the therapeutic effect of chemokines. Results: Analysis of the antitumor efficacy in a subcutaneous A549 lung tumor model mice showed a significant delay in tumor growth and no systemic toxicity was detected. Discussion: In conclusion, we have established a CLH nanodrug platform that enables efficient lung tumor therapy through combined photothermal/chemodynamic therapy (CDT) treatment and self-supplying H 2 O 2 to achieve cascade catalysis, leading to explosive amplification of oxidative stress.
multidisciplinary sciences
What problem does this paper attempt to address?